Medterra
PrivateLast Round
Debt
Mar 4, 2026
Total Funding Raised
$10.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Medterra is a consumer non-durables company that manufactures and sells a range of cannabidiol (CBD) products including tinctures, capsules, topicals, and pet products.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce, Home & Lifestyle, Sports & Fitness
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medterra Comparables
Compare Medterra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PureKana | 92% | |
| CBDfx | 90% | |
| Lazarus Naturals | 88% | |
Medterra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 4, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
$10.4M debt round closed.
Medterra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medterra's valuation, stock price, and market status.